Palleos Healthcare Gmbh
Clinical trials sponsored by Palleos Healthcare Gmbh, explained in plain language.
-
Immunotherapy window before chemo tested in aggressive breast cancer
Disease control TerminatedThis study looked at whether giving a two-week 'window' of the immunotherapy drug atezolizumab alone before starting chemotherapy could improve outcomes for people with triple-negative breast cancer. The trial enrolled 442 participants and compared this approach to starting atezo…
Phase: PHASE2 • Sponsor: Palleos Healthcare GmbH • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
App aims to tame chemo side effects in breast cancer patients
Symptom relief TerminatedThis study tested a smartphone app called medidux™ to see if it could help track and reduce serious side effects in people with HER2-positive breast cancer undergoing chemotherapy and targeted therapy. The trial planned to enroll 196 adults but was stopped early. The app was desi…
Phase: NA • Sponsor: Palleos Healthcare GmbH • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC